Hanfords US Vet Go-Dry Dry Cow Mastitis Treatment

Details

ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms that cause mastitis in dry cows. 

• ToMORROW has been an effective prolonged therapy treatment for more than 25 years, and studies have shown no change in the development of bacterial resistance.^1,2

• ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by  Streptococcus agalactiae  and  Staphylococcus aureus  including penicillin-resistant strains.

• ToMORROW is formulated with cephapirin benzathine to provide broad spectrum and long-acting therapy that dry cows need.

Features & Benefits

TOP REASONS TO USE ToMORROW^® (cephapirin benzathine)

• Shorter milk withhold.
  72 hours after calving versus 96 hours for QUARTERMASTER means you can put your cows back into production sooner after calving. 

• Shorter slaughter withhold.
  42 days after last infusion with ToMORROW treatment compared to 60 days for QUARTERMASTER allows you to move 18 days faster. 

• Targets the bacteria most common at dry-off.
  ToMORROW treatment effectively controls Gram-positive organisms, which represent 94% of infections that occur during dry-off.¹ 

• Less expensive, equally effective.
  Producers and vets can save an average of 35% per cow when treating with ToMORROW vs. SPECTRAMAST DC.³ 

• Increases convenience and reduces the risk of new infections.
  The Opti-Sert^® tip reduces new mastitis infections by up to 50%⁴ and makes partial insertion much easier.

Dosage & Administration

Presentations

• Pail containing 144 x 10-mL syringes and 144 convenient single-use alcohol pads.

• Cartons containing 12 x 10-mL syringes with 12 convenient single-use alcohol pads. 

Partial insertion reduces new infections

• With the Opti-Sert^® applicator tip, partial insertion reduces the incidence of new infections during the dry period.⁴

• Studies have shown that when infusing into the udder at a depth of 2 to 3 millimeters, as opposed to 5 or more millimeters, new intramammary infections can be reduced by as much as 50 percent.⁴ 

Dosage Information

• Infuse a 10-mL syringe (300 mg cephapirin activity per syringe) after each quarter has been completely milked out.